WAVD Stock Discussion

Firefly Neuroscience, Inc. Description

Firefly is an Artificial Intelligence (“AI”) technology company dedicated to developing groundbreaking neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA) platform revolutionizes diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has invested approximately $60 million in developing its BNA platform, building a comprehensive database of brain wave tests, securing patent protection, and achieving FDA approval. The Company is now launching the BNA platform commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use.

Sector: Technology
Industry: Information Technology Services
Keywords: Pharmaceutical Artificial Intelligence FDA Neurological Disorders Dementia Depression Major Depressive Disorder Neurology Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Learning Disabilities Mental Disorder Psychopathology